Bioresorbable scaffolds versus metallic stents in routine PCI - The New England Journal of Medicine – 2017
Brief Summary:
In patients with stable or unstable CAD undergoing PCI, bioresorbable scaffolds are associated with similar rates of target-vessel failure (defined as death, target-vessel MI, target-vessel revascularization) as DES at 2 years. Importantly, scaffolds were associated with a 2.6% absolute increase in probable or definite device thrombosis compared to DES.Reference: http://www.ncbi.nlm.nih.gov/pubmed/28402237
Comments
Post a Comment
Drop your thoughts here, we would love to hear from you